MVIS® US Listed Pharmaceutical 25 Index
The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.
Index Performance
Index performance of price, total return net and total return gross indexes is displayed in real-time.
Period | MVPPH | MVPPHTRG | MVPPHTR |
Year-to-Date Performance | 1.76% | 3.47% | 3.14% |
1-Year Performance | 18.14% | 20.61% | 20.10% |
3-Year Performance | 28.96% | 36.89% | 35.25% |
5-Year Performance | 22.97% | 35.93% | 33.21% |
Since Inception (29 Sep 2000) | 148.80% | 217.29% | 283.38% |
Index Records
Index highs and lows of price, total return net and total return gross indices are displayed in realtime.
Period | MVPPH | MVPPHTRG | MVPPHTR |
All Time High/Low | 2,637.89 / 551.16 | 3,314.68 / 976.33 | 4,007.15 / 560.95 |
52-Weeks High/Low | 2,605.98 / 2,114.60 | 3,314.68 / 2,642.74 | 4,007.15 / 3,206.36 |
Quarter High/Low | 2,487.97 / 2,487.97 | 3,172.94 / 3,172.94 | 3,833.77 / 3,833.77 |
Month High/Low | 2,575.66 / 2,487.97 | 3,284.78 / 3,172.94 | 3,968.90 / 3,833.77 |
Index Volatility
Index Volatility are updated daily.
Index Volatility | |
1-month Volatility | 10.87 |
1-year Volatility | 12.73 |
Component Performance
Displayed are the best and worst index components over a selected period of time. Data is updated daily.
Best 5 Components | 1-Year | Year-to-Date | 1-Day |
ABBVIE INC | 14.92% | -5.50% | -0.54% |
ASTRAZENECA PLC-SPONS ADR | 24.22% | 0.48% | -1.46% |
BRISTOL-MYERS SQUIBB CO | -15.93% | -17.57% | -0.33% |
JOHNSON & JOHNSON | -2.32% | -10.24% | -0.39% |
ELI LILLY & CO | 68.26% | 48.31% | 0.22% |
MERCK & CO. INC. | 22.31% | -5.68% | -0.39% |
NOVARTIS AG-ADR | 37.38% | 15.11% | -0.31% |
NOVO-NORDISK A/S-SPONS ADR | 85.94% | 36.88% | 0.95% |
PFIZER INC | -19.28% | -31.65% | 2.32% |
SANOFI-ADR | 44.77% | 13.65% | -0.11% |
TEVA PHARMACEUTICAL-SP ADR | 24.04% | 9.76% | -1.86% |
CENCORA INC | 33.88% | 9.00% | -0.49% |
MCKESSON CORP | 29.46% | 17.13% | 0.59% |
ZOETIS INC | 17.51% | 18.65% | -0.72% |
PERRIGO CO PLC | -9.22% | -5.80% | -1.85% |
MYLAN NV | 23.49% | -6.48% | 1.93% |
JAZZ PHARMACEUTICALS PLC | -4.17% | -19.82% | -1.32% |
PATTERSON COMPANIES INC | 28.73% | 9.22% | 0.57% |
CATALENT INC | -38.39% | -0.96% | -2.09% |
BAUSCH HEALTH COS INC | 17.31% | 29.83% | -1.68% |
ELANCO ANIMAL HEALTH INC | -11.68% | -10.31% | -2.49% |
TAKEDA PHARM-ADR | 19.75% | -0.44% | -1.23% |
ORGANON & CO | -25.18% | -38.02% | -3.86% |
GSK PLC-SPON ADR | 27.57% | 5.78% | -0.44% |
HALEON PLC | 37.57% | 4.73% | -0.72% |
Worst 5 Components | 1-Year | Year-to-Date | 1-Day |
ABBVIE INC | 14.92% | -5.50% | -0.54% |
ASTRAZENECA PLC-SPONS ADR | 24.22% | 0.48% | -1.46% |
BRISTOL-MYERS SQUIBB CO | -15.93% | -17.57% | -0.33% |
JOHNSON & JOHNSON | -2.32% | -10.24% | -0.39% |
ELI LILLY & CO | 68.26% | 48.31% | 0.22% |
MERCK & CO. INC. | 22.31% | -5.68% | -0.39% |
NOVARTIS AG-ADR | 37.38% | 15.11% | -0.31% |
NOVO-NORDISK A/S-SPONS ADR | 85.94% | 36.88% | 0.95% |
PFIZER INC | -19.28% | -31.65% | 2.32% |
SANOFI-ADR | 44.77% | 13.65% | -0.11% |
TEVA PHARMACEUTICAL-SP ADR | 24.04% | 9.76% | -1.86% |
CENCORA INC | 33.88% | 9.00% | -0.49% |
MCKESSON CORP | 29.46% | 17.13% | 0.59% |
ZOETIS INC | 17.51% | 18.65% | -0.72% |
PERRIGO CO PLC | -9.22% | -5.80% | -1.85% |
MYLAN NV | 23.49% | -6.48% | 1.93% |
JAZZ PHARMACEUTICALS PLC | -4.17% | -19.82% | -1.32% |
PATTERSON COMPANIES INC | 28.73% | 9.22% | 0.57% |
CATALENT INC | -38.39% | -0.96% | -2.09% |
BAUSCH HEALTH COS INC | 17.31% | 29.83% | -1.68% |
ELANCO ANIMAL HEALTH INC | -11.68% | -10.31% | -2.49% |
TAKEDA PHARM-ADR | 19.75% | -0.44% | -1.23% |
ORGANON & CO | -25.18% | -38.02% | -3.86% |
GSK PLC-SPON ADR | 27.57% | 5.78% | -0.44% |
HALEON PLC | 37.57% | 4.73% | -0.72% |